Concepedia

Nadja Sparding

NS

Statistics

Publications

11

Citations

326

H-Index

11

Active since

2014

Affiliations

Nordic Bioscience (Denmark)(Current)

University of Copenhagen

Charles University

Institute of Clinical and Experimental Medicine

Aarhus University Hospital

Nadja Sparding is an author at Nordic Bioscience (Denmark) specializing in medicine, renal pathophysiology, and renal pathology.

ORCID

Publications per year

2014–2023

11

Publications

11

RAAS inhibitors directly reduce diabetes‐induced renal fibrosis via growth factor inhibition

Sándor Kőszegi, Ágnes Molnár, Lilla Lénárt et al. · The Journal of Physiology · 2018 · 96 citations · Full text

, , +17

Endotrophin, a collagen type VI-derived matrikine, reflects the degree of renal fibrosis in patients with IgA nephropathy and in patients with ANCA-associated vasculitis

Nadja Sparding, Federica Genovese, Daniel Guldager Kring Rasmussen et al. · Nephrology Dialysis Transplantation · 2021 · 57 citations · Full text

, , +17

Reduced <i>O</i>-GlcNAcylation and tubular hypoxia contribute to the antifibrotic effect of SGLT2 inhibitor dapagliflozin in the diabetic kidney

Judit Hodrea, Dóra Balogh, Ádám Hosszú et al. · American Journal of Physiology-Renal Physiology · 2020 · 52 citations · Full text

, , +17

Pretransplant endotrophin predicts delayed graft function after kidney transplantation

Martin Tepel, Firas Farisi Alkaff, Daan Kremer et al. · Scientific Reports · 2022 · 18 citations · Full text

, , +11

Biomarkers of fibrosis, kidney tissue injury and inflammation may predict severity and outcome of renal ANCA – associated vasculitis

Veronika Satrapová, Nadja Sparding, Federica Genovese et al. · Frontiers in Immunology · 2023 · 18 citations · Full text

, , +17

1–5 of 11